195 results
8-K
EX-99.1
MLAB
Mesa Laboratories, Inc.
8 Apr 24
Mesa Labs Announces Amendment to Credit Facility and Repurchase of Senior Convertible Notes
8:00am
of the Company’s 2025 Notes will remain outstanding, and the Company will have $125.5 million of long-term debt outstanding under its Term Loan and the Revolver
8-K
EX-99.1
MLAB
Mesa Laboratories, Inc.
6 Nov 23
Mesa Labs Announces Second Quarter Results
8:00am
of the long-term health of the division. Additionally, we are beginning to see increasing quote activity in the Biopharmaceutical Development division although … , a decline of 800 bps as compared to the same quarter prior year and well below our long-term target of high 50’s to low 60’s primarily as a result
8-K
EX-99.1
MLAB
Mesa Laboratories, Inc.
18 Oct 23
Mesa Labs Acquires GKE-GmbH
1:26pm
will complement our SDC division’s strength in biologic indicators and life science channels placing both businesses in a position for robust long-term growth
8-K
EX-99.1
u7mrbn
3 Aug 23
Mesa Labs Announces First Quarter Results
8:00am
8-K
EX-99.1
gh96szftz69
25 May 23
Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results
8:00am
8-K
im65cde5ota
8 May 23
Departure of Directors or Certain Officers
8:00am
8-K
EX-99.1
0gzt uo30r9shh
3 Nov 22
Mesa Labs Announces Second Quarter Results
8:01am
DEFA14A
4yq397b e0klkkq
23 Aug 22
Additional proxy soliciting materials
11:20am
DEFA14A
zym18tq xft58mv
19 Aug 22
Additional proxy soliciting materials
7:54pm
8-K
EX-99.1
pdidajz
31 May 22
Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results
8:00am